|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
231 a.a.
|
 |
|
|
|
|
|
|
|
243 a.a.
|
 |
|
|
|
|
|
|
|
1119 a.a.
|
 |
|
|
|
|
|
|
|
1504 a.a.
|
 |
|
|
|
|
|
|
|
95 a.a.
|
 |
|
|
|
|
|
|
|
349 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transcription,transferase
|
 |
|
Title:
|
 |
Crystal structure of thermus thermophilus RNA polymerase holoenzyme in complex with the antibiotic myxopyronin
|
|
Structure:
|
 |
DNA-directed RNA polymerase subunit alpha. Chain a, b, k, l. Chain: a, b, k, l. Bacterial RNA polymerase beta subunit. Chain c, m. Chain: c, m. Bacterial RNA polymerase beta-prime subunit. Chain d, n. Chain: d, n. Bacterial RNA polymerase omega subunit. Chain e, o. Chain: e, o.
|
|
Source:
|
 |
Thermus thermophilus hb8. Organism_taxid: 300852. Organism_taxid: 300852
|
|
Resolution:
|
 |
|
3.00Å
|
R-factor:
|
0.235
|
R-free:
|
0.289
|
|
|
Authors:
|
 |
K.Das,E.Arnold
|
Key ref:
|
 |
J.Mukhopadhyay
et al.
(2008).
The RNA polymerase "switch region" is a target for inhibitors.
Cell,
135,
295-307.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
24-Jul-08
|
Release date:
|
14-Oct-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q5SHR6
(RPOA_THET8) -
DNA-directed RNA polymerase subunit alpha from Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
315 a.a.
231 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
Q5SHR6
(RPOA_THET8) -
DNA-directed RNA polymerase subunit alpha from Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
315 a.a.
243 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
Q8RQE9
(RPOB_THET8) -
DNA-directed RNA polymerase subunit beta from Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1119 a.a.
1119 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
Q8RQE8
(RPOC_THET8) -
DNA-directed RNA polymerase subunit beta' from Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1524 a.a.
1504 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D, E, F, K, L, M, N, O, P:
E.C.2.7.7.6
- DNA-directed Rna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
RNA(n)
|
+
|
ribonucleoside 5'-triphosphate
|
=
|
RNA(n+1)
Bound ligand (Het Group name = )
matches with 55.56% similarity
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Cell
135:295-307
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
The RNA polymerase "switch region" is a target for inhibitors.
|
|
J.Mukhopadhyay,
K.Das,
S.Ismail,
D.Koppstein,
M.Jang,
B.Hudson,
S.Sarafianos,
S.Tuske,
J.Patel,
R.Jansen,
H.Irschik,
E.Arnold,
R.H.Ebright.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The alpha-pyrone antibiotic myxopyronin (Myx) inhibits bacterial RNA polymerase
(RNAP). Here, through a combination of genetic, biochemical, and structural
approaches, we show that Myx interacts with the RNAP "switch region"--the hinge
that mediates opening and closing of the RNAP active center cleft--to prevent
interaction of RNAP with promoter DNA. We define the contacts between Myx and
RNAP and the effects of Myx on RNAP conformation and propose that Myx functions
by interfering with opening of the RNAP active-center cleft during transcription
initiation. We further show that the structurally related alpha-pyrone
antibiotic corallopyronin (Cor) and the structurally unrelated
macrocyclic-lactone antibiotic ripostatin (Rip) function analogously to Myx. The
RNAP switch region is distant from targets of previously characterized RNAP
inhibitors, and, correspondingly, Myx, Cor, and Rip do not exhibit
crossresistance with previously characterized RNAP inhibitors. The RNAP switch
region is an attractive target for identification of new broad-spectrum
antibacterial therapeutic agents.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. RNAP Clamp, RNAP Switch Region, and Antibiotics
Studied (A) Conformational states of the RNAP clamp (two
orthogonal views). Structure of RNAP showing open (red), partly
closed (yellow), and fully closed (green) clamp conformations,
as observed in crystal structures (PDB 1I3Q, PDB 1HQM, PDB
1I6H). Circle, switch region; dashed circle, binding site for
rifamycins; violet sphere, active-center Mg^2+. (B)
Conformational states of the RNAP switch region (stereoview).
Structure of RNAP switch 1 and RNAP switch 2 (β′ residues
1304–1329 and β′ residues 330–349; residues numbered as
in E. coli RNAP) showing conformational states associated with
open (red), partly closed (yellow), and fully closed (green)
clamp conformations, as observed in crystal structures (PDB
1I3Q, PDB 1HQM, PDB 1I6H). Gray squares, points of connection of
switch 1 and switch 2 to the RNAP main mass. Colored circles,
points of connection of switch 1 and switch 2 to the RNAP clamp.
(C) Structures of myxopyronin A (Myx), corallopyronin A
(Cor), and ripostatin A (Rip).
|
 |
Figure 4.
Figure 4. Structural Basis of Transcription Inhibition by
Myx: Structure of the RNAP-Myx Complex (A) Overall
structure (two orthogonal views; β′ nonconserved region and
σ omitted for clarity). View orientations are as in Figure 1A.
Green, Myx; violet sphere, active-center Mg^2+. (B) Myx
binding region (stereoview). Residues are numbered both as in T.
thermophilus RNAP and as in E. coli RNAP (in parentheses).
Green, Myx; red, sites of single-residue substitutions that
confer high-level resistance to Myx.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Cell Press:
Cell
(2008,
135,
295-307)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Das,
S.E.Martinez,
J.D.Bauman,
and
E.Arnold
(2012).
HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism.
|
| |
Nat Struct Mol Biol,
19,
253-259.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Fabbretti,
C.O.Gualerzi,
and
L.Brandi
(2011).
How to cope with the quest for new antibiotics.
|
| |
FEBS Lett,
585,
1673-1681.
|
 |
|
|
|
|
 |
T.I.Moy,
A.Daniel,
C.Hardy,
A.Jackson,
O.Rehrauer,
Y.S.Hwang,
D.Zou,
K.Nguyen,
J.A.Silverman,
Q.Li,
and
C.Murphy
(2011).
Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus.
|
| |
FEMS Microbiol Lett,
319,
176-179.
|
 |
|
|
|
|
 |
A.Tupin,
M.Gualtieri,
J.P.Leonetti,
and
K.Brodolin
(2010).
The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site.
|
| |
EMBO J,
29,
2527-2537.
|
 |
|
|
|
|
 |
D.Pupov,
N.Miropolskaya,
A.Sevostyanova,
I.Bass,
I.Artsimovitch,
and
A.Kulbachinskiy
(2010).
Multiple roles of the RNA polymerase {beta}' SW2 region in transcription initiation, promoter escape, and RNA elongation.
|
| |
Nucleic Acids Res,
38,
5784-5796.
|
 |
|
|
|
|
 |
J.Wu,
Q.Long,
and
J.Xie
(2010).
(p)ppGpp and drug resistance.
|
| |
J Cell Physiol,
224,
300-304.
|
 |
|
|
|
|
 |
K.J.Simmons,
I.Chopra,
and
C.W.Fishwick
(2010).
Structure-based discovery of antibacterial drugs.
|
| |
Nat Rev Microbiol,
8,
501-510.
|
 |
|
|
|
|
 |
K.J.Weissman,
and
R.Müller
(2010).
Myxobacterial secondary metabolites: bioactivities and modes-of-action.
|
| |
Nat Prod Rep,
27,
1276-1295.
|
 |
|
|
|
|
 |
O.Erol,
T.F.Schäberle,
A.Schmitz,
S.Rachid,
C.Gurgui,
M.El Omari,
F.Lohr,
S.Kehraus,
J.Piel,
R.Müller,
and
G.M.König
(2010).
Biosynthesis of the myxobacterial antibiotic corallopyronin A.
|
| |
Chembiochem,
11,
1253-1265.
|
 |
|
|
|
|
 |
P.C.Burrows,
N.Joly,
and
M.Buck
(2010).
A prehydrolysis state of an AAA+ ATPase supports transcription activation of an enhancer-dependent RNA polymerase.
|
| |
Proc Natl Acad Sci U S A,
107,
9376-9381.
|
 |
|
|
|
|
 |
S.Tagami,
S.Sekine,
T.Kumarevel,
N.Hino,
Y.Murayama,
S.Kamegamori,
M.Yamamoto,
K.Sakamoto,
and
S.Yokoyama
(2010).
Crystal structure of bacterial RNA polymerase bound with a transcription inhibitor protein.
|
| |
Nature,
468,
978-982.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.J.Lane,
and
S.A.Darst
(2010).
Molecular evolution of multisubunit RNA polymerases: structural analysis.
|
| |
J Mol Biol,
395,
686-704.
|
 |
|
|
|
|
 |
A.Ivetac,
and
J.A.McCammon
(2009).
Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations.
|
| |
J Mol Biol,
388,
644-658.
|
 |
|
|
|
|
 |
A.Rogozina,
E.Zaychikov,
M.Buckle,
H.Heumann,
and
B.Sclavi
(2009).
DNA melting by RNA polymerase at the T7A1 promoter precedes the rate-limiting step at 37 degrees C and results in the accumulation of an off-pathway intermediate.
|
| |
Nucleic Acids Res,
37,
5390-5404.
|
 |
|
|
|
|
 |
A.Tupin,
M.Gualtieri,
K.Brodolin,
and
J.P.Leonetti
(2009).
Myxopyronin: a punch in the jaws of bacterial RNA polymerase.
|
| |
Future Microbiol,
4,
145-149.
|
 |
|
|
|
|
 |
B.P.Hudson,
J.Quispe,
S.Lara-González,
Y.Kim,
H.M.Berman,
E.Arnold,
R.H.Ebright,
and
C.L.Lawson
(2009).
Three-dimensional EM structure of an intact activator-dependent transcription initiation complex.
|
| |
Proc Natl Acad Sci U S A,
106,
19830-19835.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Grohmann,
A.Hirtreiter,
and
F.Werner
(2009).
RNAP subunits F/E (RPB4/7) are stably associated with archaeal RNA polymerase: using fluorescence anisotropy to monitor RNAP assembly in vitro.
|
| |
Biochem J,
421,
339-343.
|
 |
|
|
|
|
 |
J.Wu,
and
J.Xie
(2009).
Magic spot: (p) ppGpp.
|
| |
J Cell Physiol,
220,
297-302.
|
 |
|
|
|
|
 |
S.C.Wenzel,
and
R.Müller
(2009).
The impact of genomics on the exploitation of the myxobacterial secondary metabolome.
|
| |
Nat Prod Rep,
26,
1385-1407.
|
 |
|
|
|
|
 |
S.T.Rutherford,
C.L.Villers,
J.H.Lee,
W.Ross,
and
R.L.Gourse
(2009).
Allosteric control of Escherichia coli rRNA promoter complexes by DksA.
|
| |
Genes Dev,
23,
236-248.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
| |